Beijing Cancer Hospital /ID# 252303

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

Non-Hodgkin Lymphoma

Studies at this site

• A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma — Running, not enrolling